Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Abstract Background More than 80% of adult patients diagnosed with cancer survive long term. Long-term complications of cancer and its therapies may increase the...

Abstract In addition to showing antidiabetic effects, sodium–glucose cotransporter 2 (SGLT2) inhibitors also reduce cardiovascular events in patients with type 2 diabetes mellitus. In...

AbstractAims. There is controversy regarding the incidence and outcomes of pulmonary embolism (PE) according to sex. Our aim was to address sex differences in...

Abstract. Hypoxia-inducible factors HIF-1 and HIF-2 are master regulators of oxygen homeostasis that regulate the expression of thousands of genes in order to...

Abstract Background Empagliflozin reduces cardiovascular death (CVD) or heart failure (HF) hospitalization (HFH) in patients with HF and preserved ejection fraction. Treatment effects and...

IntroductionInflammation and oxidative stress are critical to the pathogenesis of cardiovascular diseases (CVDs) including atherosclerosis and heart failure. Proinflammatory cytokines, including tumor necrosis factor-α...

Join Chair Anne Marie Valente, MD, FACC and Chair Emeritus Patrick T. O’Gara, MD, MACC for ACC’s Cardiovascular Overview and Board Prep Virtual Experience!...

June 21, 2022 7:00 PM iCal Meeting Type: Webinars – OnDemand Location: Online – Eastern Time (ET) Join ACC for a new series put...

Men, older patients and patients with low income were among those with elevated risk for CVD hospitalization prior to receiving a diagnosis of potentially...

  • 1539932609815478274 Profile photo of Madelyn

    #CVD burden in #cancer varies by sex, age, income, and cancer subtype. #heartdisease is a major threat factor for people in cancer treatment. Oncologists need to work in collaboration with cardiologists to ensure good patient care. https://t.co/QYi3IgkWI5 - view on twitter

Salim Hayek, MD,...